Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


NL - FR - EN

Coagulation factors

HUMAN FIBRINOGEN: FibCLOT

Therapeutic indications:

- treatment and perioperative prophylaxis of bleeding in patients with congenital hypo- or afibrinogenaemia with bleeding tendency.

Factane 1000 I.U. (10 ml)
Therapeutic indications:
- treatment and prophylaxis to prevent bleeding in patients with haemophilia A (congenital Factor VIII deficiency)
- treatment of inhibitors through immune tolerance induction

Nonafact 1000 I.U. (10 ml) and 500 I.U. (5 ml) 
Therapeutic indications:
- treatment and prophylaxis to prevent bleeding in patients with haemophilia B (congenital Factor IX deficiency)

Wilfactin 1000 I.U. (10 ml)
Therapeutic indications:
- specially designated for the preventive and curative treatment of haemorrhaging or surgical bleeding
  associated with von Willebrand Disease (type 3).

Cofact
For reasons of harmonization of registration between different countries within Europe, we have decided to replace PPSB-SD 500 IU by Cofact ® 500 IU.

Therapeutic indications:

- Treatment of bleeding and perioperative prophylaxis of bleeding in acquired deficiency of the prothrombin
complex coagulation factors, such as deficiency caused by treatment with vitamin K antagonists, or in case of
overdose of vitamin K antagonists, when rapid correction of the deficiency is required.

- Treatment of bleeding and perioperative prophylaxis in congenital deficiency of any of the vitamin K dependent
coagulation factors when purified specific coagulation product is not available.